Warfarin Sodium
- Product NDC
- 50090-2582
- 11-digit product format
- 500902582
- Labeler code
- 50090
- Product ID
- 50090-2582_f5ab4257-9ef0-4164-a3bc-ad78583ac7e9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Warfarin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA202202
- Marketing category
- ANDA
- Marketing start
- 2010-08-16
- Substance
- WARFARIN SODIUM
- Active strength
- 7.5 mg/1
- Pharmacologic classes
- Vitamin K Antagonist [EPC], Vitamin K Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Warfarin Sodium
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| WARFARIN SODIUM | 7.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 6153CWM0CL |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 50090-2582-0 | 2020-12-15 | C162847 | 48780-1 | 9d75b9cf-cdbe-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use WARFARIN SODIUM TABLETS safely and effectively. See full prescribing information for WARFARIN SODIUM TABLETS. WARFARIN SODIUM tablets (crystalline), for oral use Initial U.S. Approval: 1954 |
| 50090-2582-0 | 2020-12-15 | C162847 | 48780-1 | 9d75b9cf-cdbe-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use WARFARIN SODIUM TABLETS safely and effectively. See full prescribing information for WARFARIN SODIUM TABLETS. WARFARIN SODIUM tablets (crystalline), for oral use Initial U.S. Approval: 1954 |
| 50090-2582-1 | 2020-12-15 | C162847 | 48780-1 | 9d75b9cf-cdbe-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use WARFARIN SODIUM TABLETS safely and effectively. See full prescribing information for WARFARIN SODIUM TABLETS. WARFARIN SODIUM tablets (crystalline), for oral use Initial U.S. Approval: 1954 |
| 50090-2582-1 | 2020-12-15 | C162847 | 48780-1 | 9d75b9cf-cdbe-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use WARFARIN SODIUM TABLETS safely and effectively. See full prescribing information for WARFARIN SODIUM TABLETS. WARFARIN SODIUM tablets (crystalline), for oral use Initial U.S. Approval: 1954 |
| 50090-2582-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-cdbe-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use WARFARIN SODIUM TABLETS safely and effectively. See full prescribing information for WARFARIN SODIUM TABLETS. WARFARIN SODIUM tablets (crystalline), for oral use Initial U.S. Approval: 1954 |
| 50090-2582-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-cdbe-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use WARFARIN SODIUM TABLETS safely and effectively. See full prescribing information for WARFARIN SODIUM TABLETS. WARFARIN SODIUM tablets (crystalline), for oral use Initial U.S. Approval: 1954 |
| 50090-2582-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-cdbe-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use WARFARIN SODIUM TABLETS safely and effectively. See full prescribing information for WARFARIN SODIUM TABLETS. WARFARIN SODIUM tablets (crystalline), for oral use Initial U.S. Approval: 1954 |
| 50090-2582-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-cdbe-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use WARFARIN SODIUM TABLETS safely and effectively. See full prescribing information for WARFARIN SODIUM TABLETS. WARFARIN SODIUM tablets (crystalline), for oral use Initial U.S. Approval: 1954 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-2582-0 | Warfarin Sodium | 30 in 1 BOTTLE | TABLET | 30 | | 51 |
| 50090-2582-1 | Warfarin Sodium | 90 in 1 BOTTLE | TABLET | 90 | | 51 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-2582 | WARFARIN SODIUM (WARFARIN) TABLET [A-S MEDICATION SOLUTIONS] | 51 | Current NDC, Legacy NDC, 2 package rows | 20250410_541c9a70-adaf-4ef3-94ba-ad4e70dfa057.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-2582-0 | 50090258200 | 30 TABLET in 1 BOTTLE (50090-2582-0) | 30 tablet | 2016-11-01 | 0000-00-00 | No | No | Current |
| 50090-2582-1 | 50090258201 | 90 TABLET in 1 BOTTLE (50090-2582-1) | 90 tablet | 2017-01-11 | 0000-00-00 | No | No | Current |